T. Amaral , E. Chatziioannou , A. Nuebling , T. Sinnberg , H. Niessner , U. Leiter , J. Dwarkasing , T. Arentsen , C. Groß , A. Eggermont , L. Flatz , S. Forchhammer
{"title":"在未接受前哨淋巴结活检的黑色素瘤患者独立队列中通过梅林检测(CP-GEP)识别复发高风险患者:头颈部亚组分析","authors":"T. Amaral , E. Chatziioannou , A. Nuebling , T. Sinnberg , H. Niessner , U. Leiter , J. Dwarkasing , T. Arentsen , C. Groß , A. Eggermont , L. Flatz , S. Forchhammer","doi":"10.1016/j.ejcskn.2024.100126","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":100396,"journal":{"name":"EJC Skin Cancer","volume":"2 ","pages":"Article 100126"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772611824001149/pdfft?md5=19f25064e5ecf1fdeb4979ec9e994a0e&pid=1-s2.0-S2772611824001149-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Identification of patients at high risk for relapse by Merlin Assay (CP-GEP) in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy: head and neck subgroup analysis\",\"authors\":\"T. Amaral , E. Chatziioannou , A. Nuebling , T. Sinnberg , H. Niessner , U. Leiter , J. Dwarkasing , T. Arentsen , C. Groß , A. Eggermont , L. Flatz , S. Forchhammer\",\"doi\":\"10.1016/j.ejcskn.2024.100126\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":100396,\"journal\":{\"name\":\"EJC Skin Cancer\",\"volume\":\"2 \",\"pages\":\"Article 100126\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2772611824001149/pdfft?md5=19f25064e5ecf1fdeb4979ec9e994a0e&pid=1-s2.0-S2772611824001149-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EJC Skin Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772611824001149\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJC Skin Cancer","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772611824001149","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Identification of patients at high risk for relapse by Merlin Assay (CP-GEP) in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy: head and neck subgroup analysis